Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?
Eating disorders strike nearly 1 in 10 Americans, with the second-highest death rate of all psychiatric disorders. The pandemic's food insecurity, stockpiling and stress are triggering flare-ups.
There's a lot that scientists don't know about how viral infections can interact. But researchers are eager to figure out how coronavirus infections might affect flu infections and vice versa.
NPR's Mary Louise Kelly talks with Moncef Slaoui, chief adviser for the coronavirus vaccine development program, Operation Warp Speed, about the status of vaccines in the U.S.
Scientists say new drugs are on the way for patients with ALS. The latest is a two-drug combo that appears to slow the progression of the fatal nerve disease with a modest but meaningful benefit.
Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.
New studies strongly support the use of corticosteroids to treat COVID-19. These drugs are inexpensive and widely available. Early controversy over their effectiveness may now largely be settled.
A vaccine against the coronavirus needs to keep people from getting very sick and dying. But preventing the spread of the disease is also important, and vaccines delivered by nasal spray may do that.
Emily Miller was central in defending the FDA commissioner, Dr. Stephen Hahn, after he falsely said that blood plasma could lower the death rate from COVID-19 by more than a third.
New vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year.
A frontline doctor and advocate for Georgia's immigrant and refugee populations on supporting and encouraging some of the people most vulnerable to COVID-19.
Young athletes — especially girls — can struggle with a breathing problem that appears to be asthma. The real cause of the problem is in the vocal cords.
An uninsured Colorado man who had appendicitis owed $80,232 after two surgeries. After months of negotiating with the hospital, he still owes far more than most insurers would pay for the procedures.
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.
NPR's Ari Shapiro talks with Dr. Eric Topol of the Scripps Research Translational Institute about his concerns about the use of convalescent plasma for COVID-19 treatment.
